American Association of Pharmaceutical Scientists (AAPS),
Do you need greater discovery-development integration to improve efficiency and success of bringing new medicines to patients?
Translating Molecules into Medicines
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Pharmaceutical Industry Performance
-
Altmetric BadgeChapter 2 New Product Planning and the Drug Discovery-Development Interface
-
Altmetric BadgeChapter 3 Target Engagement Measures in Preclinical Drug Discovery: Theory, Methods, and Case Studies
-
Altmetric BadgeChapter 4 In Silico ADME Techniques Used in Early-Phase Drug Discovery
-
Altmetric BadgeChapter 5 Discover Toxicology: An Early Safety Assessment Approach
-
Altmetric BadgeChapter 6 Integrated Lead Optimization: Translational Models as We Advance Toward the Clinic
-
Altmetric BadgeChapter 7 Developability Assessment of Clinical Candidates
-
Altmetric BadgeChapter 8 Lead Optimization, Preclinical Toxicology
-
Altmetric BadgeChapter 9 Design of Clinical Studies in Early Development
-
Altmetric BadgeChapter 10 Design of Clinical Formulations in Early Development
-
Altmetric BadgeChapter 11 Translational Research: Preclinical to Healthy Volunteer to Patient
-
Altmetric BadgeChapter 12 Regulatory Aspects at the Drug Discovery Development Interface
-
Altmetric BadgeChapter 13 Alternate Routes of Administration
-
Altmetric BadgeChapter 14 Outlook for the Future